A rare hantavirus outbreak aboard an international cruise ship attracted worldwide attention, with members of the public left wondering whether this was the beginning of the next pandemic.
Here, we hear from Mara Jana Broadhurst, microbiologist and infectious disease expert at the University of Nebraska Medical Center, who shares the latest knowledge – and dispels some of the misinformation – as this situation continues to unfold.
What factors make cruise ships particularly vulnerable to disease transmission?
Cruise ships facilitate the spread of infectious diseases because they involve large numbers of people living, dining, and interacting in close proximity. Pathogens that spread through respiratory secretions, contaminated surfaces, or food are particularly well suited to transmission in these settings.
Which infectious diseases are most commonly encountered on cruise ships?
The most common outbreaks reported on cruise ships involve gastrointestinal infections, such as norovirus, and respiratory infections, including COVID-19 and influenza. Although these illnesses are typically self-limited, they can cause more severe disease in older adults and individuals with underlying health conditions. Travelers should be aware of these risks when spending time in crowded environments and consider appropriate preventive measures, particularly during periods of increased respiratory virus activity.
How common are hantavirus outbreaks in this setting?
The reported hantavirus outbreak linked to a cruise ship appears to be an uncommon event, and there is currently no evidence to suggest an increased risk of hantavirus outbreaks on other vessels. Investigations are ongoing to determine how the virus was introduced. At present, there is no indication that concerns about hantaviruses should deter individuals from cruise travel.
As with any travel setting, awareness of public health advisories and adherence to infection prevention measures remain important. Because rodents can carry a range of infectious pathogens, effective rodent control and minimizing exposure to rodent urine and droppings are important components of outbreak prevention in ports, transportation hubs, and other travel-related environments.
Based on the information currently available, how concerning is this hantavirus situation from a public health perspective?
Public health authorities are actively implementing measures to reduce the risk of transmission and ensure that exposed individuals are appropriately monitored. Andes hantavirus does not spread easily between people. Documented transmission has required close and prolonged contact, rather than casual interaction. With appropriate precautions, including infection prevention practices in healthcare settings, the risk of broader community spread is low.
What are the main diagnostic challenges clinicians and laboratories face in identifying hantavirus cases early?
Early symptoms of hantavirus infection – including fever, fatigue, headache, and muscle aches – are nonspecific and can resemble those of many other viral illnesses, making clinical diagnosis difficult. Laboratory diagnosis can also be challenging early in the course of infection because antibodies may not be detectable until symptoms have developed.
Hantavirus infection is most commonly diagnosed using serologic tests that detect antibodies produced in response to the virus. These tests are generally reliable once symptoms are present, but they may yield negative results during the earliest stages of infection.
Molecular testing can also be used to detect hantavirus RNA in blood samples. PCR-based assays may identify infection before antibodies become detectable and can be particularly useful early in disease. However, these tests are specialized, have limited availability, and are typically performed in public health, reference, or research laboratories.
How long may exposed passengers need to be monitored or isolated, and what factors determine the level of risk following exposure?
The incubation period of Andes virus is thought to be up to six weeks long. Individuals with high-risk exposures may be monitored for the duration of the incubation period. The level of risk of person-to-person transmission is primarily determined by the nature and duration of exposure to someone who was ill with Andes virus infection.
In situations like this, how do public health teams distinguish between routine infectious disease events and outbreaks that warrant greater concern or escalation?
Outbreaks of mild respiratory and food-borne illnesses are relatively common and may go undetected or unreported. Greater public health concern arises when an infectious disease is associated with severe illness, person-to-person transmission, or limited treatment and prevention options. When these factors coincide – as they can with Andes virus – rapid public health action and infection control measures are essential to identify cases, limit transmission, and prevent further spread.
What are the key responsibilities for pathologists and laboratory professionals when responding to rare infectious disease events?
Pathologists play a central role in the diagnosis and management of infectious diseases. Through laboratory testing and collaboration with clinicians and public health officials, they help identify pathogens, support accurate diagnosis, and inform patient care and public health responses. Pathologists and laboratory professionals are also instrumental in developing, validating, and implementing diagnostic tests for emerging infectious threats. In addition, they help ensure that testing is performed safely and in accordance with biosafety standards, reducing the risk of laboratory-acquired infections.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
